Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -85.56% is 37% below its 5-year average of -62.31%, around the middle of its 5-year range (-149.87%–-31.42%).
As of the fiscal period ended Tuesday, June 30, 2026. 24.82% above its 12-month average of -113.81%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -85.56%.
RETURN ON INVESTED CAPITAL (ROIC)
-85.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-113.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-77.70%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-62.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+24.82%
CURRENT VS 3Y AVG
-10.12%
CURRENT VS 5Y AVG
-37.32%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.80%
median of 696 covered companies
CURRENT VS SECTOR MEDIAN
-153.14%
vs the sector median at left
Cabaletta Bio, Inc.
Market Cap
$330.19M
Return on Invested Capital (ROIC)
-85.56%
TTM Avg
-113.81%
3Y Avg
-77.70%
5Y Avg
-62.31%
Market Cap
$331.69M
Return on Invested Capital (ROIC)
-40.51%
TTM Avg
-48.13%
3Y Avg
-48.38%
5Y Avg
-39.85%
Market Cap
$336.05M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-35.18%
3Y Avg
-129.73%
5Y Avg
-103.61%
Market Cap
$321.27M
Return on Invested Capital (ROIC)
-164.32%
TTM Avg
-159.25%
3Y Avg
-125.06%
5Y Avg
-125.06%
Market Cap
$321.26M
Return on Invested Capital (ROIC)
-35.92%
TTM Avg
-35.67%
3Y Avg
-36.59%
5Y Avg
-30.23%
Market Cap
$320.33M
Return on Invested Capital (ROIC)
-136.92%
TTM Avg
-105.47%
3Y Avg
-71.42%
5Y Avg
-55.10%
Market Cap
$309.22M
Return on Invested Capital (ROIC)
-122.21%
TTM Avg
-122.21%
3Y Avg
-122.21%
5Y Avg
-122.21%
Market Cap
$352.32M
Return on Invested Capital (ROIC)
-56.73%
TTM Avg
-80.02%
3Y Avg
-65.94%
5Y Avg
-165.76%
Market Cap
$355.58M
Return on Invested Capital (ROIC)
-30.78%
TTM Avg
-151.81%
3Y Avg
-134.98%
5Y Avg
-109.65%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | $330.19M | -85.56% | -113.81% | -77.70% | -62.31% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $331.69M | -40.51% | -48.13% | -48.38% | -39.85% |
| Agenus Inc. (AGEN)vs › | $336.05M | N/A | -35.18% | -129.73% | -103.61% |
| CapsoVision, Inc. (CV)vs › | $321.27M | -164.32% | -159.25% | -125.06% | -125.06% |
| C4 Therapeutics, Inc. (CCCC)vs › | $321.26M | -35.92% | -35.67% | -36.59% | -30.23% |
| Avita Medical Inc. (RCEL)vs › | $320.33M | -136.92% | -105.47% | -71.42% | -55.10% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $309.22M | -122.21% | -122.21% | -122.21% | -122.21% |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $352.32M | -56.73% | -80.02% | -65.94% | -165.76% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $355.58M | -30.78% | -151.81% | -134.98% | -109.65% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $355.18M | -24.20% | -33.45% | -34.14% | -28.75% |
ROIC
-85.6%
ROE
-86.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -85.56% |
| 2026-03-31 | -138.26% |
| 2025-12-31 | -149.87% |
| 2025-09-30 | -113.46% |
| 2025-06-30 | -81.92% |
| 2025-03-31 | -102.36% |
| 2024-12-31 | -79.22% |
| 2024-09-30 | -63.08% |
| 2024-06-30 | -50.18% |
| 2024-03-31 | -38.54% |
| 2023-12-31 | -31.42% |
| 2023-09-30 | -41.69% |
| 2023-06-30 | -34.59% |
| 2023-03-31 | -61.71% |
| 2022-12-31 | -50.37% |
| 2022-09-30 | -60.24% |
| 2022-06-30 | -53.93% |
| 2022-03-31 | -46.48% |
| 2021-12-31 | -39.26% |
| 2021-09-30 | -35.80% |
| 2021-06-30 | -38.10% |
| 2021-03-31 | -34.51% |
| 2020-12-31 | -30.89% |
| 2020-09-30 | -25.84% |
| 2020-06-30 | -21.65% |
| 2020-03-31 | -17.15% |
| 2019-12-31 | -13.51% |
| 2019-09-30 | -20.71% |
| 2019-06-30 | -17.03% |
| 2018-12-31 | -18.64% |
